COSCIENS Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	9.59	7.14	14.57	5.26	3.65	Upgrade
Revenue Growth (YoY)	34.22%	-50.98%	177.03%	44.03%	586.47%	Upgrade
Cost of Revenue	4.86	4.21	6.02	0.09	2.32	Upgrade
Gross Profit	4.73	2.94	8.56	5.17	1.34	Upgrade
Selling, General & Admin	6.37	5.53	2.87	7.27	5.89	Upgrade
Research & Development	8.3	2.04	1.37	6.57	1.51	Upgrade
Other Operating Expenses	-	-	-	-	-0.14	Upgrade
Operating Expenses	14.67	7.57	4.24	13.84	7.26	Upgrade
Operating Income	-9.94	-4.63	4.32	-8.67	-5.93	Upgrade
Interest Expense	-0.13	-0.14	-0.14	-0.01	-0	Upgrade
Interest & Investment Income	0.44	0.06	0.15	-	-	Upgrade
Currency Exchange Gain (Loss)	0.05	-0.02	0.21	0.22	0.57	Upgrade
Other Non Operating Income (Expenses)	2.7	0.36	-0.01	-0.01	0.42	Upgrade
EBT Excluding Unusual Items	-6.89	-4.37	4.53	-8.48	-4.94	Upgrade
Merger & Restructuring Charges	-4.08	-	-	-	-	Upgrade
Asset Writedown	-4.26	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	0.22	Upgrade
Pretax Income	-15.23	-4.37	4.53	-8.48	-4.72	Upgrade
Income Tax Expense	0.08	-0.89	1.08	-0.11	0.4	Upgrade
Earnings From Continuing Operations	-15.31	-3.49	3.45	-8.37	-5.12	Upgrade
Net Income	-15.31	-3.49	3.45	-8.37	-5.12	Upgrade
Net Income to Common	-15.31	-3.49	3.45	-8.37	-5.12	Upgrade
Shares Outstanding (Basic)	3	2	2	1	0	Upgrade
Shares Outstanding (Diluted)	3	2	2	1	0	Upgrade
Shares Change (YoY)	39.74%	-0.39%	61.37%	179.74%	134.83%	Upgrade
EPS (Basic)	-5.93	-1.89	1.87	-7.28	-12.46	Upgrade
EPS (Diluted)	-5.93	-1.89	1.86	-7.28	-12.46	Upgrade
Free Cash Flow	-15.73	-3.3	4.93	-8.61	-4.13	Upgrade
Free Cash Flow Per Share	-6.09	-1.79	2.66	-7.49	-10.05	Upgrade
Gross Margin	49.33%	41.13%	58.71%	98.29%	36.55%	Upgrade
Operating Margin	-103.70%	-64.81%	29.65%	-164.85%	-162.24%	Upgrade
Profit Margin	-159.69%	-48.79%	23.66%	-159.09%	-140.14%	Upgrade
Free Cash Flow Margin	-164.07%	-46.26%	33.80%	-163.71%	-113.06%	Upgrade
EBITDA	-8.68	-3.47	5.79	-8.53	-5.69	Upgrade
EBITDA Margin	-90.52%	-48.62%	39.72%	-162.09%	-155.89%	Upgrade
D&A For EBITDA	1.26	1.16	1.47	0.15	0.23	Upgrade
EBIT	-9.94	-4.63	4.32	-8.67	-5.93	Upgrade
EBIT Margin	-103.70%	-64.81%	29.65%	-164.85%	-162.24%	Upgrade
Effective Tax Rate	-	-	23.85%	-	-	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q